For the next Blizard / DERI bioinformatics forum we have the prospect of a great talk from Gabriel Rosser of BenevolentAI.
Date: Wednesday 3 April, 12.30pm-1.30pmVenue: Clark-Kennedy Lecture Theatre
BenevolentAI is an AI-augmented drug discovery company uniting science and technology to develop life-changing medicines for patients. In this talk, Gabriel will give an overview of the way the company integrates vast quantities of biomedical data across modalities in the service of drug discovery. We’ll cover the Benevolent Data Foundation – a uniquely comprehensive and diverse Knowledge Graph containing insights from literature, omics and structured ontological data amongst other sources. Then we’ll discuss the platform we’ve built on top of it – including some of the AI and bioinformatics at play – before taking a more detailed look at our cutting-edge language-based model and how we are using it to reason across more than just scientific literature.
Gabriel is a bioinformatics data scientist at BenevolentAI, a drug discovery biotech company. He leads the bioinformatics function within teams responsible for the target discovery process, including data exploration, model development and software tools. Their tech platform, combined with the biological expertise of the users, augments the process of running drug programmes through a combination of AI and informatics. Before moving to the biotech industry, Gabriel was a bioinformatics postdoc at the Blizard Institute in the Marino lab researching glioblastoma. He had a wonderful time there and is looking forward to coming back for this talk!